Integra Lifesciences Holdings (IART) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.59% |
| Dec 31, 2025 | -54.70% |
| Sep 30, 2025 | -12.79% |
| Jun 30, 2025 | -124.53% |
| Mar 31, 2025 | -15.70% |
| Dec 31, 2024 | 37.60% |
| Sep 30, 2024 | -17.24% |
| Jun 30, 2024 | -87.15% |
| Mar 31, 2024 | 75.83% |
| Dec 31, 2023 | 39.58% |
| Sep 30, 2023 | -27.17% |
| Jun 30, 2023 | 8.00% |
| Mar 31, 2023 | -72.42% |
| Dec 31, 2022 | 26.24% |
| Sep 30, 2022 | -25.30% |
| Jun 30, 2022 | 14.63% |
| Mar 31, 2022 | -47.43% |
| Dec 31, 2021 | 120.21% |
| Sep 30, 2021 | 30.28% |
| Jun 30, 2021 | -26.83% |
| Mar 31, 2021 | -30.76% |
| Dec 31, 2020 | 33.18% |
| Sep 30, 2020 | 20.98% |
| Jun 30, 2020 | -60.63% |
| Mar 31, 2020 | 59.29% |
| Dec 31, 2019 | 31.19% |
| Sep 30, 2019 | 31.95% |
| Jun 30, 2019 | 17.26% |
| Mar 31, 2019 | 18.70% |
| Dec 31, 2018 | -65.50% |
| Sep 30, 2018 | 5.56% |
| Jun 30, 2018 | -30.07% |
| Mar 31, 2018 | 33.73% |
| Dec 31, 2017 | -58.93% |
| Sep 30, 2017 | 46.42% |
| Jun 30, 2017 | 6.77% |
| Mar 31, 2017 | 19.84% |
| Dec 31, 2016 | 36.11% |
| Sep 30, 2016 | 24.40% |
| Jun 30, 2016 | -19.17% |
| Mar 31, 2016 | 24.32% |
| Dec 31, 2015 | -21.30% |
| Sep 30, 2015 | -25.37% |
| Jun 30, 2015 | 20.50% |
| Mar 31, 2015 | -3.37% |
| Dec 31, 2014 | -21.13% |
| Sep 30, 2014 | 17.77% |